It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Knowing when to opt for index funds over stocks helps you prioritize diversification and lower maintenance while pursuing gains.
25,835 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Applied Optoelectronics and Lumentum surged as Texas expansion plans lift demand for AI optics components, boosting r...
SK Hynix shares surged 14% ahead of its July 29 earnings, fueling a broader rebound in memory and AI chip stocks. Mic...
In a striking contrast, Nancy Pelosi buys bullish calls on Amazon as Berkshire Hathaway scales back its Amazon exposu...
As shipping cycles turn, Safe Bulkers faces a critical earnings season. This guide deconstructs the Q4 2025 call, hig...
Investors are focusing on the links between battlefield tech and defense earnings as analysts highlight the firearms ...
Oil prices surge on renewed tensions around the Strait of Hormuz, with U.S. crude and Brent rising as traders weigh p...
QuantumScape's solid-state battery efforts could redefine EV charging. This guide digs into what might drive QS stock...
Analysts warn that Nvidia's GTC event may not deliver the dramatic stock move some investors were banking on. The con...
AI is reshaping big tech, but not all bets are the same. This guide weighs Microsoft and Amazon on AI power, cash flo...
A seasoned investor at Benchmark warns that the AI boom may be inflating prices beyond fundamentals, signaling a comi...
Through March 21, 2026, VT is down less than 1% year-to-date while SPY slides about 3%, signaling a shift toward glob...